Ursprung des Netzwerks ersten Grades von Michel Sazonov
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.
7
| Holding Company | Medical Specialties | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michel Sazonov
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process. | Investment Managers | Portfolio Manager-Equities | |
BOIRON | Pharmaceuticals: Other | Director/Board Member | |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investment Managers | Private Equity Investor | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director of Finance/CFO | |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Biotechnology | Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree | |
Université de Technologie de Compiègne | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree | |
Université Claude Bernard Lyon 1 | College/University | Corporate Officer/Principal | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member | |
NANOBIOTIX | Medical Specialties | Director/Board Member | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member | |
Proviciel SA
Proviciel SA Packaged SoftwareTechnology Services Proviciel SA design and develops secure industrial web applications. Its PEPS enables user to do messaging and share files. The company was founded by Henri Binsztok on December 24, 2008 and is headquartered in Paris, France. | Packaged Software | Chairman | |
Camilla SNC
Camilla SNC Financial ConglomeratesFinance Part of Société Générale SA, Camilla SNC is an investment holding French company. The company is based in Puteaux, France and was founded in 2005. | Financial Conglomerates | Corporate Officer/Principal | |
BALYO | Industrial Machinery | Director/Board Member | |
Holding ISF Masseran Technologies | Director/Board Member | ||
Lucane Pharma SA
Lucane Pharma SA Pharmaceuticals: MajorHealth Technology Lucane Pharma SA produces pharmaceutical products. It develops medicines for niche therapeutics areas. The company was founded by Pierre Mambrini and Pamela Lewis and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
Indicia Production SASU
Indicia Production SASU BiotechnologyHealth Technology Indicia Production SASU provides biotechnology research and development services. It manufactures ready-to-use microbiological media for the food and pharmaceutical industry. The company was founded in 1993 and is headquartered in Saint-Genis-l'Argentiere, France. | Biotechnology | Chief Executive Officer | |
Platine Pharma Services SAS
Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Based in Lyon within the Center of excellence in Infectious Diseases, Platine Pharma Services is an essential source of immune information for scientists and clinicians. From protocol support to regulatory reports, the company designs, performs and interprets complex molecular and cellular assays. Platine actively supports the development of in-vitro diagnostic, cosmetic and therapeutic product candidates, highlighting key markers and features in both normal and pathological conditions, and guiding decisions at each development stage. Using state-of-the-art technologies such as multi-parametric flow cytometry, Singulex, Luminex, Mesoscale Discovery, ELISpot or ELISA, Platine Pharma Services offers a fit-for-purpose approach to its customers and partners. | Medical/Nursing Services | Chief Executive Officer | |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services BioAster operates as a research institute. The private company is based in Lyon, France. The CEO of the French company is Nathalie Garçon. | Miscellaneous Commercial Services | Director/Board Member | |
BIOCORP | Medical Specialties | Director/Board Member | |
Transcure Bioservices SAS
Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Indicia Développement SA | Chairman | ||
Mabdesign Association
Mabdesign Association Miscellaneous Commercial ServicesCommercial Services MabDesign Association is a French biotherapy industry association that aims to structure the biopharmaceutical industry from its R&D phases to biomanufacturing and marketing. The private company is based in Lyon, France and was founded in 2014. The association offers services to help companies strengthen their competitiveness and implement a solid intellectual property strategy. MabDesign's board of directors is composed of a pharmaceutical industry college and a competitiveness cluster college. The CEO is Nicolas Groux. | Miscellaneous Commercial Services | Chairman | |
Eligo Bioscience SA
Eligo Bioscience SA Medical/Nursing ServicesHealth Services Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France. | Medical/Nursing Services | Director/Board Member | |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Medical Specialties | Director/Board Member | |
Sci La Parliere | Corporate Officer/Principal | ||
SkinJay SAS
SkinJay SAS Specialty StoresRetail Trade SkinJay SAS operates online store for oils, perfume and skin care products. The firm offer Pluie de Printemps, Draps de Brume, Pschht and Rosee Ravageuse. The company’s Skinjay mirror is a shower mixer and a unique collection of aromatic capsules, attached to the shower hose. The firm’s Skinjay mixer is based on a proprietary technology micro-nebulization. The company was founded by Nicolas Pasquier in 2012 and is headquartered in Paris, France. | Specialty Stores | Director/Board Member | |
Kreaxi SASU
Kreaxi SASU Investment ManagersFinance Kreaxi SASU (Kreaxi) is an independent private equity firm born from the merger of Rhône-Alpes Création and Banexi Ventures Partners. The company is headquartered in Paris, France. | Investment Managers | Private Equity Investor | |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Director/Board Member | |
Indicia Participations
Indicia Participations Financial ConglomeratesFinance Indicia Participations functions as an investment holding French company. The private company is based in Saint-Genis-l'Argentière, France. | Financial Conglomerates | Chairman | |
SCI CALIFORNIE
SCI CALIFORNIE Real Estate DevelopmentFinance SCI CALIFORNIE is a French company that leases real estate properties. | Real Estate Development | Corporate Officer/Principal | |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès. | Medical Specialties | Director/Board Member | |
NH THERAGUIX SAS | Pharmaceuticals: Major | Director/Board Member Founder Founder | |
33 Californie SAS (Lentilly) | Chairman | ||
Simba Sante 3 SAS | Investment Managers | Chairman | |
Monatomics Technology SAS | Director/Board Member | ||
La Financière du Faouet SASU | Chairman | ||
Jalon Therapeutics
Jalon Therapeutics Pharmaceuticals: MajorHealth Technology Jalon Therapeutics is a French company that aims to develop innovative therapies to treat cancer by inactivating vital tumor signaling pathways. Jalon Therapeutics is based in Paris, France and manages an extensive candidate portfolio of drug candidates infused by its unique expertise in AAC-11 biology. The company leverages their deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. The company's lead candidate, JRT39, is the first-in-class drug developed for the treatment of hard-to-treat cancers. The company is building a drug discovery platform to develop other candidates derived from AAC-11 and AAC-11 partners for the treatment of cancer. Jalon Therapeutics raised a pre-seed in 2022, leveraged by non-dilutive and quasi-equity fundings from public institutions. The company's growth ambition is to raise a seed immediately followed by a series A to finance up to the clinical proof of concept of their lead candidate JRT39. The company was founded in 2021 by Jérôme Tiollier, Jean-Luc Poyet, Prof. Martine Bagot, Prof. Hervé Dombret, Jean-Christophe Rain, and Philippe Salphati. The CEO is David Loison. | Pharmaceuticals: Major | Director/Board Member | |
SNOWPACK
SNOWPACK Information Technology ServicesTechnology Services Snowpack is a European spin-off from CEA List that provides a next-generation network security solution. The private company is based in Europe and offers DarkSnow and RedSnow plans for accessing the dark web and performing tests live from anywhere in the world. The French company combines privacy and security on the internet through a unique overlay network that ensures complete invisibility. Snowpack's network overlay is defined as an "Ethical, Verifiable and No-trust Tor-like Overlay Network with unmatched Security and Performance". Standard terms apply, and illegal use is not allowed. | Information Technology Services | Chief Executive Officer | |
GLOBAL BIOENERGIES | Chemicals: Specialty | Director/Board Member |
Statistik
International
Frankreich | 46 |
Schweden | 2 |
Sektoral
Health Technology | 16 |
Finance | 9 |
Commercial Services | 7 |
Consumer Services | 5 |
Technology Services | 3 |
Operativ
Director/Board Member | 28 |
Chairman | 12 |
Founder | 8 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 5 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Marc Le Bozec | 16 |
Stéphane Legastelois | 16 |
Sébastien Groyer | 15 |
Sandra Dubos | 3 |
Olivier Tillement | 3 |
Francois Lux | 2 |
Thomas Brichart | 1 |
- Börse
- Insiders
- Michel Sazonov
- Unternehmensverbindungen